Because it's a long road from the mouse to approval! The fact that the arsenal is growing is fantastic. This indication needs a partnership! FDA may be spot on with GSK.
This is big, we now have the cells doing positive things on two fronts in the oncology sector. Todays announcement and restoration of bloodlines after radiation exposure (Cancer radiation treatment side effect). Great stuff, and this is a published study!